Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Okoro

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Health Psychology Open|December 17, 2020
Risk and protective factors for intention of contraception use among women in GhanaManik Ahuja, Esther Frimpong, Joy Okoro, et al.
Psychological Reports|December 31, 2021
Feeling Not Wanted/Loved and Depression: Does Gender Matter?Manik Ahuja, Joy Okoro, Esther Frimpong, et al.
American Journal of Cancer Research|March 14, 2025
A novel gemcitabine analog as a potential anticancer agent: synthesis and <i>in-vitro</i> evaluation against pancreatic cancerJoy Okoro, Raviteja Bulusu, Esther Frimpong, et al.
International Journal of Public Health|September 30, 2022
An Assessment of Systemic Factors and COVID-19 Mortality in AfricaAyomide Owoyemi, Tolulope Balogun, Joy Okoro, et al.
American Journal of Cancer Research|March 14, 2025
Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based studyEsther Frimpong, Eugene Annor, Raviteja Bulusu, et al.
American Journal of Cancer Research|September 15, 2025
Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancerRaviteja Bulusu, Joy Okoro, Esther Frimpong, et al.
International Journal of Pharmaceutics: X|April 24, 2026
Anti-EGFR liposomal drug delivery system loaded with AGY<sub>2</sub> potentiates the anti-cancer effect of AGY<sub>2</sub> against EGFR expressed pancreatic cancerRaviteja Bulusu, Esther Frimpong, Joy Okoro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2024
Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancerEsther Frimpong, Raviteja Bulusu, Joy Okoro, et al.
Environmental Research|November 2, 2020
Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stressOgbebor Enaholo Omoike, Robert P Pack, Hadii M Mamudu, et al.
International Journal of Molecular Sciences|March 11, 2023
Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic CancerNkafu Bechem Ndemazie, Raviteja Bulusu, Xue You Zhu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Health Psychology Open|December 17, 2020
Risk and protective factors for intention of contraception use among women in GhanaManik Ahuja, Esther Frimpong, Joy Okoro, et al.
Psychological Reports|December 31, 2021
Feeling Not Wanted/Loved and Depression: Does Gender Matter?Manik Ahuja, Joy Okoro, Esther Frimpong, et al.
American Journal of Cancer Research|March 14, 2025
A novel gemcitabine analog as a potential anticancer agent: synthesis and <i>in-vitro</i> evaluation against pancreatic cancerJoy Okoro, Raviteja Bulusu, Esther Frimpong, et al.
International Journal of Public Health|September 30, 2022
An Assessment of Systemic Factors and COVID-19 Mortality in AfricaAyomide Owoyemi, Tolulope Balogun, Joy Okoro, et al.
American Journal of Cancer Research|March 14, 2025
Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based studyEsther Frimpong, Eugene Annor, Raviteja Bulusu, et al.
American Journal of Cancer Research|September 15, 2025
Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancerRaviteja Bulusu, Joy Okoro, Esther Frimpong, et al.
International Journal of Pharmaceutics: X|April 24, 2026
Anti-EGFR liposomal drug delivery system loaded with AGY<sub>2</sub> potentiates the anti-cancer effect of AGY<sub>2</sub> against EGFR expressed pancreatic cancerRaviteja Bulusu, Esther Frimpong, Joy Okoro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2024
Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancerEsther Frimpong, Raviteja Bulusu, Joy Okoro, et al.
Environmental Research|November 2, 2020
Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stressOgbebor Enaholo Omoike, Robert P Pack, Hadii M Mamudu, et al.
International Journal of Molecular Sciences|March 11, 2023
Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic CancerNkafu Bechem Ndemazie, Raviteja Bulusu, Xue You Zhu, et al.
Pageof 2